![](/img/cover-not-exists.png)
Phase I/II Study of Bortezomib Plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
Dreicer, R., Petrylak, D., Agus, D., Webb, I., Roth, B.Volume:
13
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-06-2046
Date:
February, 2007
File:
PDF, 278 KB
english, 2007